Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection

Sponsor
Instituto Nacional de Cancer, Brazil (Other)
Overall Status
Completed
CT.gov ID
NCT03740815
Collaborator
(none)
15
1
1
29.2
0.5

Study Details

Study Description

Brief Summary

INTRODUCTION: The axillary lymphadenectomy procedure is known to be associated with late postoperative complications, such as chronic pain and changes in shoulder mobility. Recently, several thoracic ultrasound guided interfascial blocks have been described, including serratus plane block. These blocks were associated with reduced postoperative pain scores in breast surgeries but were never evaluated in axillary dissection. The safety and feasibility of performing axillary dissection under local anesthesia and tumescent anesthesia associated with sedation has been demonstrated in case series, although it is not already the standard technique.

DISCUSSION: This project aims to investigate the feasibility of the serratus plane block associated with intra-venous sedation in a prospective case series including 15 patients submitted to axillary dissection, by scoring patient and surgeon satisfaction with the technique, pain, quality of life with EORTC QLQ-C30 questionnaire, and quality of recovery with QoR-40 questionnaire in the first 30 postoperative days.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Serratus plane block
  • Procedure: Axillary dissection
  • Procedure: Intravenous sedation
N/A

Detailed Description

This study is a prospective case series. All patients should go through a preoperative evaluation with an anesthesiologist. At that time the eligibility for the study will be evaluated and if the patient consent to participate in the study.

The following parameters shall be evaluated in the ambulatory evaluation:
  • Age

  • Anthropometric data (weight and height);

  • Presence of comorbidities;

  • Revised cardiac index (LEE);

  • Estimation of functional capacity in metabolic equivalents (METs) by history;

  • Performance Status by the scale of Eastern Cooperative Oncology Group (ECOG);

  • Determination of the physical status by the American Society of Anesthesiologists (ASA) classification;

  • QoR-40 recovery quality scale, validated for Brazilian Portuguese;

  • Quality of life EORTC QLQ-C30 questionnaire, validated for Brazilian Portuguese.

During the anesthetic procedure, the following standard technique should be applied:

peripheral venous access, dipyrone 30 mg/kg, antibiotic according to the institutional protocol, moderate sedation with intravenous propofol in continuous infusion in the absence of any contraindication. Midazolam will be used in case of contraindication to propofol or during the execution of the block according to preference of the researcher who will perform the block. Associated with propofol infusion, the alpha agonist dexmedetomidine may be used in continuous infusion associated with fentanyl, tramadol, dextroketamine, magnesium sulfate, dipyrone and tenoxicam, whose uses will be evaluated on a case-by-case basis and will be recorded in the database.

In case of conversion to general anesthesia, the airway control should be carried out preferably with laryngeal mask, with the orotracheal intubation as an alternative option. The maintenance of anesthesia will be in this case using propofol continuous infusion in the absence of contraindications, otherwise sevoflurane will be used. Postoperative nausea and vomiting prophylaxis will be done with four milligrams of dexamethasone and ondansetron.

Patients will be submitted serratus plane block according to the technique described in Blanco. The patients will be positioned in a supine position. The transducer of the ultrasound device is protected with sterile cover. The ultrasound probe is positioned in the mid clavicular region of the thoracic wall in a sagittal plane. Using a nether-lateral path with the probe, will be counted the ribs, until the fifth rib is identified in the mid axillary line. In this position, over the fifth rib, the latissimus dorsi muscle superficially and the serratus muscle deeper and lower can be easily observed. The identification of the thoracodorsal artery with use of doppler imaging assists in identifying the superficial plane to the serratus muscle. Once identified the structures, the needle is introduced in the plane of the transducer positioning its tip on the surface of the serratus muscle. Then 40 ml of solution with 1% lidocaine, adrenaline 1:200,000 and ropivacaine 0.5% are injected in patients above 50kg and 32ml of the same solution in patients with body weight between 40 and 50kg aiming to respect the maximum dose of local anesthetic recommended.

At the end of the surgical procedure the patient will be referred to the anesthetic recovery unit. The extension of the blockade will be then evaluated. They will be discharged to ward as soon as they get the discharge criteria.

The surgical time, time for execution of the blockage (counted from the placement of the sterile field until the removal of the needle), the surgical room time, estimated bleeding, presence of surgical complications or anesthetic and number of lymph nodes extracted will be registered. At the end of the surgery the surgeon will be asked to fill out a range of Likert 5 points on his opinion on the quality of anesthesia (extremely satisfied, satisfied, not satisfied or dissatisfied, dissatisfied, extremely dissatisfied) and to compare the quality of anesthesia with general anesthesia on a 3-point scale (indistinguishable from general anesthesia, sufficient to perform the procedure, extremely challenging/inadequate).

On the first day of postoperative the standard analgesia will be carried out with dipyrone 30 mg/kg IV every 4 hours, associated with tenoxicam 20mg every 12 hours. In case of contraindication to dipyrone, will be administered paracetamol 500 mg VO every 6 hours. As a rescue therapy the default option is tramadol 50mg IV up to every 4 hours (daily maximum dose of 300mg/day and morphine 4 mg each hour (in case of allergy or intolerance to tramadol and rescue the tramadol). If necessary more than 24 hours of hospitalization, postoperative analgesia will be performed as option of the assistant team. The use of postoperative painkillers will be recorded in the database.

All patients should be evaluated on the first postoperative day with record of the verbal numerical scale for the evaluation of pain at rest, cough and abduction of 90 Degrees of the member and the presence of adverse effects. They be asked to fill the scale of Likert of 5 points with his opinion on the quality of anesthesia (extremely satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, extremely dissatisfied) and the scale of recovery quality QoR-40. Between the twenty-eighth and the thirtieth-fifth postoperative day All patients will be reassessed, occasion where the scale of recovery quality QoR-40 and the scale of quality of life EORTC QLQ-C30, presence of surgical wound infection will be applied, cutaneous necrosis, seroma, lymphedema, lymphatic fistula and date of drain removal.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessment of the Feasibility of Ultrasound Guided Serratus Plane Block Associated With Sedation as Anesthetic Technique in Axillary Dissection
Actual Study Start Date :
Sep 25, 2018
Actual Primary Completion Date :
Mar 2, 2021
Actual Study Completion Date :
Mar 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Serratus plane block plus sedation

Serratus plane block plus intravenous sedation as anesthetic technique during axillary dissection procedure.

Procedure: Serratus plane block
Ultrasound guided injection of local anesthetic between latissimus dorsi and serratus muscles at mid axillary line.

Procedure: Axillary dissection
Axillary dissection is a surgical procedure that incises the axilla to identify, examine, or remove lymph nodes.
Other Names:
  • Axillary limphadenectomy
  • Procedure: Intravenous sedation
    Administration of sedatives thru an intravenous access to achieve relaxion and improve operative conditions.
    Other Names:
  • Sedation
  • Outcome Measures

    Primary Outcome Measures

    1. Percentage of patients who needed conversion to general anesthesia [Intraoperative]

      Percentage of patients who needed conversion to general anesthesia. A percentage from 0 to 100%, where 0% means that no patient needs technique conversion to general anesthesia and 100% means that all patients need it.

    Secondary Outcome Measures

    1. The 30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. [Preoperative and in Postoperative day 30]

      The QLQ-C30 is composed of multi-item scales and single-item measures. These include: A global health status / QoL scale Five functional scales (Physical functioning, Role functioning, Emotional functioning, Cognitive functioning, Social functioning) Three symptom scales (Fatigue, Nausea and vomiting, Pain) Six single items (Dyspnoea, Insomnia, Appetite loss, Constipation, Diarrhoea, Financial difficulties) Each of the multi-item scales includes a different set of items. All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. Thus a high score for a functional scale represents a high / healthy level of functioning, a high score for the global health status / QoL represents a high QoL, but a high score for a symptom scale / item represents a high level of symptomatology / problems . The scales are scored as described as described in EORTC QLQ-C30 Scoring Manual. 2001 EORTC, Brussels.

    2. QoR-40 questionnaire [Preoperative, First postoperative day visit and in Postoperative day 30]

      Quality of Recovery - 40 Item questionnaire QoR-40 score is a score developed to estimate the quality of recovery after anesthesia. It consists of a 40-item questionnaire with items on a five- point Likert scale (for positive items, 1 'none of the time' to 5 'all of the time'; for negative items the scoring was reversed). It is scored as follows: QoR-40 dimensions Emotional state (9-45) Physical comfort (12-60) Psychological support (7-35) Physical independence (5-25) Pain (7-35) Global QoR-40 (40-200)

    3. Surgeon satisfaction - 5 points Likert scale [Imediate postoperative period]

      A five points Likert scale will be applied to the main surgeon responsible for the operation. The surgeon will be asked to fill out a Likert 5 points scale to access his opinion about the quality of anesthesia (extremely satisfied, satisfied, not satisfied or dissatisfied, dissatisfied, extremely dissatisfied).

    4. Patient satisfaction - 5 points Likert scale [First postoperative day visit]

      A five points Likert scale will be applied to the patient in the first postoperative day visit to access his opinion about the quality of the anesthesia (extremely satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, extremely dissatisfied).

    5. Numeric pain rating scale (0-10) [Preoperative, postoperative day 1 and 30]

      Eleven point numeric pain rating scale (0 means no pain and 10 means worst possible pain).

    6. Analgesic requirement [Intraoperative and postoperative day one (cumulative dose)]

      All the anesthetics and analgesics used in intraoperative and postoperative period will be recorded. Doses will be recorded in database.

    7. Number of lymph nodes extracted [Postoperative day 30 (according to anatomopathological report)]

      Number of lymph nodes extracted according to anatomopathological report.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Undergo axillary dissection due to metastatic skin or soft tissue cancer;

    • ASA physical status classification between I and III;

    • have signed the informed consent.

    Exclusion Criteria:
    • weight less than 40 kilograms;

    • tumor affecting topography to be blocked;

    • presence of ulcerated lesion in the axilla;

    • presence of coagulopathy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital do Câncer II - National Cancer Institute of Brazil (INCA - Brazil) Rio de Janeiro Rio De Janeiro/RJ Brazil 20220-410

    Sponsors and Collaborators

    • Instituto Nacional de Cancer, Brazil

    Investigators

    • Principal Investigator: Daniele Theobald, MD, National Cancer Institute of Brazil (INCA - Brazil)

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Instituto Nacional de Cancer, Brazil
    ClinicalTrials.gov Identifier:
    NCT03740815
    Other Study ID Numbers:
    • CAAE 89037818.0.0000.5274
    First Posted:
    Nov 14, 2018
    Last Update Posted:
    Apr 8, 2022
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 8, 2022